Introduction: Antibiotic resistance is a global problem that threat the public health. New patterns of antimicrobial resistance emerge daily which get through the international boundaries and easily spread. The aim of this study is to evaluate the activity of Euphorbia trigona rubra leaves crude extract on this drug resistance bacteria’s. Materials and methods: This study was carried out in natural product laboratory in collaboration with Microbiology Laboratory. Antimicrobial sensitivity patterns of the bacteria were done by using Kirby Bauer Disc Diffusion method. Antibiotics which were tested in congruent with the crude extract include Augmentin (10 μg), Amoxicillin (10 μg), Ampicillin (10 μg), Cefixime (30 μg), Ticarcillin (30 μg), Ceftazidime (30 μg), Azithromycin (15 μg), Gentamycin (10 mcg), Ciprofloxacin (10 μg), Trimethoprim-Sulfamethaxazole (10 μg), Doxycycline (30 μg), Chloramphenicol (30 μg), and Rifampicin (30 μg). Results: Euphorbia trigona rubra leaves crude extract has shown a significant activity of 21.33±0.55 mm when compared to the drug (4.63±0.71 mm, 7.33±0.55 mm, 4.00±0.06 mm, 4.58±0.21 mm, 7.11±1.00 mm, 5.97±0.87 mm, 4.63±0.71 mm, 7.33±0.55 mm, 5.00±0.06 mm, 5.58±0.21 mm, 5.97±0.87 mm, 4.63±0.71 mm, and 9.13±0.55 mm) at 500 µg/mL, respectively that the bacterium was resistance to, this shows that the crude extract from the leaves of this cactus plant has an effective activity for resistance bacteria and should be considered as an agent in the pharmaceutical industries.
Published in | Advances in Biochemistry (Volume 9, Issue 3) |
DOI | 10.11648/j.ab.20210903.11 |
Page(s) | 39-43 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Antibiotic, Pseudomonas aeruginosa, Euphorbia trigona rubra, Leaves
[1] | Pattanayak, S. (2017). Alternative to antibiotics-preparation for post antibiotic era. |
[2] | Pattanayak, S., Pal, S., Mandal, T. K., Debnath, P. K., & Bandyopadhyay, S. K. (2014). A comparative study of extract of succulent leaves of living plant with methanolic and aqueous extract of Berleria lupulina Lindl. Against pathogenic microbes by disc diffusion and spectrophotometry. Explor Anim Med Res, 4 (2), 148-157. |
[3] | Pattanayak, S. (2011). Development of resistance of bacteria against antimicrobial agents: reasons, threats and ongoing encounter. Expl Anim Med Res, 1 (1), 7-19. |
[4] | Shankar, P. R., & Upadhyay, D. K. (2005). Book Review: Pharmacology by Rang HP, Dale MM, Ritter JM and Moore PK. Churchill Livingstone, Edinburgh, 2003. Iranian Journal of Pharmacology & Therapeutics, 4 (2), 151. |
[5] | Gupta, V., Bansal, P., Kumar, S., Sannd, R., & Rao, M. M. (2010). Therapeutic efficacy of Phytochemicals as anti-anxiety-a review. J Pharm Res, 3 (1), 174-179. |
[6] | Høiby, N., Ciofu, O., & Bjarnsholt, T. (2010). Pseudomonas aeruginosa biofilms in cystic fibrosis. Future microbiology, 5 (11), 1663-1674. |
[7] | Khan, A. R., Ullah, I., Waqas, M., Shahzad, R., Hong, S. J., Park, G. S., & Shin, J. H. (2015). Plant growth-promoting potential of endophytic fungi isolated from Solanum nigrum leaves. World Journal of Microbiology and Biotechnology, 31 (9), 1461-1466. |
[8] | Gales, A. C., Jones, R. N., Turnidge, J., Rennie, R., & Ramphal, R. (2001). Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997–1999. Clinical Infectious Diseases, 32 (Supplement_2), S146-S155. |
[9] | Carmeli, Y., Samore, M. H., & Huskins, W. C. (1999). The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Archives of internal medicine, 159 (20), 2461-2468. |
[10] | Dash, R. P., Rais, R., & Srinivas, N. R. (2018). Key pharmacokinetic essentials of fixed-dosed combination products: case studies and perspectives. Clinical pharmacokinetics, 57 (4), 419-426. |
[11] | Baltch, A. L., & Smith, R. P. (1994). Pseudomonas aeruginosa: infections and treatment. Pseudomonas aeruginosa: infections and treatment. (12). |
[12] | Schmelzer, G. H., & Gurib-Fakim, A. (Eds.). (2008). Medicinal plants (Vol. 11). Prota. |
[13] | Vermeulen, N. (1999). Encyclopedia of House Plants. Taylor & Francis. |
[14] | Laurence C. (2015). Hatch “HITS: House, Interior, Tropical, and Succulent Plants: Genera D to E” Laurence Hatch Press. |
[15] | Eggli, U. (2002). Illustrated handbook of succulent plants. Springer. |
[16] | Vermeulen, S. J., Nollet, F., Teugels, E., Krist'l, M. V., Malfait, F., Philippé, J., & Mareel, M. M. (1999). The αE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene, 18 (4), 905-915. |
[17] | Eloff, J. N. (1999). The antibacterial activity of 27 southern African members of the Combretaceae. South African Journal of Science, 95 (3), 148-152. |
[18] | Javiya VA, Ghatak SB, Patel KR, Patel JA. (2008). Antibiotic susceptibility patterns of “Pseudomonas aeruginosa” at a tertiary care hospital in Gujarat, India. Indian J Pharmacol. 40: 230-4. |
[19] | Ekrem K, Rokan DK (2014). Antibiotic susceptibility patterns of “Pseudomonas aeruginosa” strains isolated from various clinical specimens. Sky J. Microbiol. Res. 2 (2): 13-17. |
[20] | Gad GF, El-Domany RA, Zaki S, Hossam M (2007) Ashour Characterization of “Pseudomonas aeruginosa” isolated from clinical and environmental samples in Minia, Egypt: prevalence, anibiogram and resistance mechanisms. Journal of Antimicrobial Chemotherapy. 60: 1010-1017. |
[21] | Rajat RM, Ninama GL, Mistry K, Parmar R, Patel K, Vegad MM. (2012). Antibiotic resistance pattern in “Pseudomonas aeruginosa” species isolated at a tertiary care Hospital, Ahmadabad. Natl J Med Res. 2: 156-9. |
[22] | Okon K, Agukwe P, Oladosu W, Balogun S, Uba A (2009). Antibiotic resistance pattern of “Pseudomonas aeruginosa” isolated from clinical specimens in a tertiary hospital in northeastern Nigeria. J. Microbiol. 8 (2): 5-7. |
[23] | Jombo GT, Jonah P, Ayeni JA (2008) Multiple resistant “Pseudomonas aeruginosa” in contemporary medical practice: Findings from urinary isolates at a Nigerian, University Teaching Hospital. Niger J Physiol Sci. 23 (1-2): 105-9. |
[24] | Shewatatek G, Gizachew T, Molalegne B, Terefe G. (2014). Drug sensitivity of “Pseudomonas aeruginosa” from wound infections in Jimma University specialized hospital, Ethiopia. J. Med. Med. Sci. Res. 3 (2): 13-18. |
[25] | Olayinka AT, Olayinka BO, Onile BA (2008) Prevalence of multi-drug resistant (MDR) “Pseudomonas aeruginosa” isolates in surgical units of Ahmadu Bello University Teaching Hospital, Zaria, Nigeria: An indication for effective control measures. Annals of African Medicine. 1: 13-16. |
[26] | Arora D, Jindal N, Kumar R, Romit (2011). Emerging antibiotic resistance in “Pseudomonas aeruginosa”. Int. J. Pharm. Sci., 3 (2): 82-4. |
[27] | Mohanasoundaram KM (2011). The antibiotic resistance pattern in the clinical isolates of “Pseudomonas aeruginosa” in a tertairy care hospital; 2008-2010 (A 3 year study). J. Clin. Diagn. Res., 5 (3): 491-94. |
APA Style
Isaac John Umaru. (2021). Antibiotic Resistance of “Pseudomonas aeruginosa” and the Effect of Euphorbia trigona rubra Leaves Crude Extract. Advances in Biochemistry, 9(3), 39-43. https://doi.org/10.11648/j.ab.20210903.11
ACS Style
Isaac John Umaru. Antibiotic Resistance of “Pseudomonas aeruginosa” and the Effect of Euphorbia trigona rubra Leaves Crude Extract. Adv. Biochem. 2021, 9(3), 39-43. doi: 10.11648/j.ab.20210903.11
AMA Style
Isaac John Umaru. Antibiotic Resistance of “Pseudomonas aeruginosa” and the Effect of Euphorbia trigona rubra Leaves Crude Extract. Adv Biochem. 2021;9(3):39-43. doi: 10.11648/j.ab.20210903.11
@article{10.11648/j.ab.20210903.11, author = {Isaac John Umaru}, title = {Antibiotic Resistance of “Pseudomonas aeruginosa” and the Effect of Euphorbia trigona rubra Leaves Crude Extract}, journal = {Advances in Biochemistry}, volume = {9}, number = {3}, pages = {39-43}, doi = {10.11648/j.ab.20210903.11}, url = {https://doi.org/10.11648/j.ab.20210903.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ab.20210903.11}, abstract = {Introduction: Antibiotic resistance is a global problem that threat the public health. New patterns of antimicrobial resistance emerge daily which get through the international boundaries and easily spread. The aim of this study is to evaluate the activity of Euphorbia trigona rubra leaves crude extract on this drug resistance bacteria’s. Materials and methods: This study was carried out in natural product laboratory in collaboration with Microbiology Laboratory. Antimicrobial sensitivity patterns of the bacteria were done by using Kirby Bauer Disc Diffusion method. Antibiotics which were tested in congruent with the crude extract include Augmentin (10 μg), Amoxicillin (10 μg), Ampicillin (10 μg), Cefixime (30 μg), Ticarcillin (30 μg), Ceftazidime (30 μg), Azithromycin (15 μg), Gentamycin (10 mcg), Ciprofloxacin (10 μg), Trimethoprim-Sulfamethaxazole (10 μg), Doxycycline (30 μg), Chloramphenicol (30 μg), and Rifampicin (30 μg). Results: Euphorbia trigona rubra leaves crude extract has shown a significant activity of 21.33±0.55 mm when compared to the drug (4.63±0.71 mm, 7.33±0.55 mm, 4.00±0.06 mm, 4.58±0.21 mm, 7.11±1.00 mm, 5.97±0.87 mm, 4.63±0.71 mm, 7.33±0.55 mm, 5.00±0.06 mm, 5.58±0.21 mm, 5.97±0.87 mm, 4.63±0.71 mm, and 9.13±0.55 mm) at 500 µg/mL, respectively that the bacterium was resistance to, this shows that the crude extract from the leaves of this cactus plant has an effective activity for resistance bacteria and should be considered as an agent in the pharmaceutical industries.}, year = {2021} }
TY - JOUR T1 - Antibiotic Resistance of “Pseudomonas aeruginosa” and the Effect of Euphorbia trigona rubra Leaves Crude Extract AU - Isaac John Umaru Y1 - 2021/08/18 PY - 2021 N1 - https://doi.org/10.11648/j.ab.20210903.11 DO - 10.11648/j.ab.20210903.11 T2 - Advances in Biochemistry JF - Advances in Biochemistry JO - Advances in Biochemistry SP - 39 EP - 43 PB - Science Publishing Group SN - 2329-0862 UR - https://doi.org/10.11648/j.ab.20210903.11 AB - Introduction: Antibiotic resistance is a global problem that threat the public health. New patterns of antimicrobial resistance emerge daily which get through the international boundaries and easily spread. The aim of this study is to evaluate the activity of Euphorbia trigona rubra leaves crude extract on this drug resistance bacteria’s. Materials and methods: This study was carried out in natural product laboratory in collaboration with Microbiology Laboratory. Antimicrobial sensitivity patterns of the bacteria were done by using Kirby Bauer Disc Diffusion method. Antibiotics which were tested in congruent with the crude extract include Augmentin (10 μg), Amoxicillin (10 μg), Ampicillin (10 μg), Cefixime (30 μg), Ticarcillin (30 μg), Ceftazidime (30 μg), Azithromycin (15 μg), Gentamycin (10 mcg), Ciprofloxacin (10 μg), Trimethoprim-Sulfamethaxazole (10 μg), Doxycycline (30 μg), Chloramphenicol (30 μg), and Rifampicin (30 μg). Results: Euphorbia trigona rubra leaves crude extract has shown a significant activity of 21.33±0.55 mm when compared to the drug (4.63±0.71 mm, 7.33±0.55 mm, 4.00±0.06 mm, 4.58±0.21 mm, 7.11±1.00 mm, 5.97±0.87 mm, 4.63±0.71 mm, 7.33±0.55 mm, 5.00±0.06 mm, 5.58±0.21 mm, 5.97±0.87 mm, 4.63±0.71 mm, and 9.13±0.55 mm) at 500 µg/mL, respectively that the bacterium was resistance to, this shows that the crude extract from the leaves of this cactus plant has an effective activity for resistance bacteria and should be considered as an agent in the pharmaceutical industries. VL - 9 IS - 3 ER -